CN104833804A - Helicobacter pylori IgG antibody ELISA semi-quantitative detection kit and application thereof - Google Patents

Helicobacter pylori IgG antibody ELISA semi-quantitative detection kit and application thereof Download PDF

Info

Publication number
CN104833804A
CN104833804A CN201510219965.4A CN201510219965A CN104833804A CN 104833804 A CN104833804 A CN 104833804A CN 201510219965 A CN201510219965 A CN 201510219965A CN 104833804 A CN104833804 A CN 104833804A
Authority
CN
China
Prior art keywords
helicobacter pylori
solution
elisa
buffer
igg antibody
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201510219965.4A
Other languages
Chinese (zh)
Inventor
刘峰
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Will Europe Han Biotechnology (hefei) Co Ltd
Original Assignee
Will Europe Han Biotechnology (hefei) Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Will Europe Han Biotechnology (hefei) Co Ltd filed Critical Will Europe Han Biotechnology (hefei) Co Ltd
Priority to CN201510219965.4A priority Critical patent/CN104833804A/en
Publication of CN104833804A publication Critical patent/CN104833804A/en
Pending legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911Bacteria
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/5436Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals with ligand physically entrapped within the solid phase
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/20Assays involving biological materials from specific organisms or of a specific nature from bacteria from Spirochaetales (O), e.g. Treponema, Leptospira

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

The invention provides a helicobacter pylori IgG antibody ELISA semi-quantitative detection kit. The kit is formed by a helicobacter pylori antigen coated enzyme labeled reaction plate, a sample diluting solution, a washing liquid, an enzyme labeled second antibody, a substrate solution, a stopping solution, a positive control solution, a negative control solution and a standard solution. A method for rapid and sensitive ELISA semi-quantitative detection of a helicobacter pylori specific IgG antibody in serum is established by using the kit. The helicobacter pylori IgG antibody standard solution is prepared, the helicobacter pylori antigen coated enzyme labeled reaction plate is prepared based on the standard solution, an indirect ELISA method is adopted to detect the specific helicobacter pylori IgG antibody in the serum, and the specific helicobacter pylori IgG antibody is quantified through calculation of an enzyme immunity unit (EIU). The kit has the advantages of high specificity and high sensitivity, and is mainly used for laboratory researches and clinic auxiliary diagnosis.

Description

A kind of Helicobacter pylori IgG Antibodies ELISA half-quantitative detection kit and application thereof
Technical field
The present invention relates to a kind of biological detection reagent kit, a specifically Helicobacter pylori IgG Antibodies ELISA half-quantitative detection kit, can be used for detecting Helicobacter pylori IgG Antibodies in serum fast and the ELISA detection kit of IgG antibody content being carried out to sxemiquantitative calculating.
Background technology
Helicobacter pylori (Helicobacter pylori, H.p), by Barry Marshall (Barry J.Marshall) and guest sieve Warren (J.Robin Warren) two people's Late Cambrian, therefore this two people obtains the Nobel prize's soul of 2005.Helicobacter pylori is the bacterium of a kind of one pole, many flagellums, the blunt circle of end, helically bent, long 2.5 ~ 4.0 μm, wide 0.5 ~ 1.0 μm.Normal in typical spiral fashion or arc on gastric epithelial cell surface.
Helicobacter pylori infections is chronic active gastritis, peptic gastric ulcer and gastric mucosa-associated lymphoid tissue (MALT) lymphadenomatous main pathogenic, and with cancer of the stomach there is Close relation.Within 1994, helicobacter pylori is decided to be I class procarcinogen by the World Health Organization (WHO)/international cancer research institution (WHO/IARC).In Asia, the infection rate difference 60%, 40%, 70% of the juvenile helicobacter pyloris such as China's Mainland, Vietnam, India, in the Gastric Biopsy of Patients with Chronic Gastritis, helicobacter pylori recall rate can reach 80% ~ 90%, and peptic gastric ulcer patient Geng Gao, can more than 95% be reached, even close to 100%.There is alienation due to topical epithelial cell in cancer of the stomach, therefore its recall rate height report differs.The stomach infections of helicobacter pylori has been a worldwide medical problem, carries out to it monitoring that Accurate Diagnosis is conducive to controls H.p spread and epidemic and elimination HP treatment of infection.
Nineteen eighty-three by gastroscope get biopsy specimen be separated cultivate successfully since, many methods have been developed to the diagnosis of helicobacter pylori infections, have included bacteriology, pathology, serology, tagging, molecular biology etc.But total says, from collection of specimens angle, invasive and the large class of Noninvasive two can be divided into.
Invasive method mainly refers to must pass through the method that biopsy specimen inspection got by gastroscope, is the conventional method of current disease for digest subject.It comprises separation cultivation and direct smear, the rapid urease test of bacterium, drug sensitive test.
Noninvasive method mainly refers to the method for not got the infection of biopsy specimen diagnosing helicobacter pylori sample by gastroscope.These class methods comprise antibody test, antigen detection, urea 13C/14C breath test etc.The current existing method of antibody test comprises euzymelinked immunosorbent assay (ELISA), Western blot, colloidal gold method and latex enhancing immune turbidimetry etc.
Serologic detection is a conventional Noninvasive detection method, is particularly useful for the area that Hp infection rate is higher.Hp causes chronic inflammation, and the immune response meeting sustainable existence of system, produces IgG antibody.Conventional serological test comprises ELISA method, rapid whole blood/method such as serum test, Western blot, and wherein ELISA method is the most frequently used.ELlSA method accuracy rate is up to 90% ~ 95%, and ELISA kit can provide the quantitative testing result of antibody, and this method is not by the impact of medicine.But regrettably at present various Helicobacter pylori IgG Antibodies ELISA detection kit is qualitative detection on domestic and international market, and IgG antibody content all has important suggesting effect for the residence density of helicobacter pylori and helicobacter pylori eradication Outcome measure.The present invention prepares Helicobacter pylori IgG Antibodies titer, adopts indirect elisa method on this basis, can carry out half-quantitative detection quickly and easily to specificity Helicobacter pylori IgG Antibodies in serum.
Summary of the invention
The invention provides a kind of helicobacter pylori IgG type antibody ELISA half-quantitative detection kit.Kit of the present invention is mainly used in the chronic gastritis instructing Helicobacter pylori infection to cause, the adjuvant clinical diagnosis of the diseases such as peptic ulcer and clinical monitoring index.
Technical solution of the present invention is as follows:
A kind of Helicobacter pylori IgG Antibodies ELISA half-quantitative detection kit, it is characterized in that: be made up of by enzyme reaction plate, sample diluent, cleansing solution, ELIAS secondary antibody, substrate solution, stop buffer, positive control solution, negative controls and titer Heliobacter pylori antigen bag
The antigen coated enzyme reaction plate of described helicobacter pylorus is prepared from through the following steps:
(1) 96 hole ELISA Plate one piece is got;
(2) multiple of Heliobacter pylori antigen coating buffer by 1:1000 is diluted, the antigen liquid diluted is added 110 μ l in each ELISA Plate hole, ELISA Plate is inserted in wet box, spent the night at 2-8 DEG C of bag;
(3) clean with cleansing solution: with cleansing solution cleaning bag by the ELISA Plate of spending the night, every hole adds 350ul cleansing solution, cleans 2-4 time;
(4) stabilizing buffer is added: every hole adds 150ul stabilizing buffer, hatches 2-4 hour, then drain under 18-25 DEG C of condition;
(5) get the antigen coated microplate drained and add 10% bovine serum albumin of 200 μ l PBS dilutions at 37 DEG C of closed 1-2 hour, obtain antigen coated enzyme reaction plate;
(6) pack: with packaging of aluminium foil bag, and put into drying agent in bag, be stored in the freezer of 2-8 DEG C after packaging;
Described coating buffer: 0.05mol/L carbonate buffer solution (pH9.6) 0.75g sodium carbonate, 1.46g sodium bicarbonate, adds deionized water and is settled to 500ml;
Described sample diluent: the phosphate buffer (PBS) of 10% bovine serum albumin+0.1%ProClin300+0.01M pH7.4;
Described cleansing solution: the phosphate buffer (PBST) of 0.05%Tween 20+0.01mol/L pH7.4;
Described ELIAS secondary antibody: the rabbit anti-Hb poly-IgG of horseradish peroxidase-labeled;
Described substrate solution: TMB-H 2o 2urea liquid;
Described stop buffer: 2mol/L H 2sO 4solution;
Described negative controls: containing human serum base helicobacter pylori IgG negative controls;
Described positive control solution: containing human serum base helicobacter pylori IgG positive control solution;
Described titer: containing human serum base helicobacter pylori IgG titer.
Described a kind of Helicobacter pylori IgG Antibodies ELISA half-quantitative detection kit detects the application in serum in Helicobacter pylori IgG Antibodies in ELISA method.
Beneficial effect
The present invention obtains a kind of kit, the present invention prepares Helicobacter pylori IgG Antibodies titer, on this basis by Heliobacter pylori antigen bag by enzyme reaction plate, adopt indirect elisa method, detect specificity Helicobacter pylori IgG Antibodies in serum, and by the calculating of enzyme immunizing unit (EIU), it is carried out quantitatively.Kit of the present invention, has high specific and susceptibility, and this kit is mainly for laboratory study and clinical assistant diagnosis.
Kit of the present invention is utilized to adopt ELISA method to detect Helicobacter pylori IgG Antibodies in serum, the testing result of kit of the present invention and the result consistance of INOVA company Helicobacter pylori IgG Antibodies ELISA detection kit high, sensitivity is 95%, and specificity is 99.5%.
Embodiment
1, reagent
(1) coating buffer: the sodium carbonate-bicarbonate damping fluid of 0.05mol/L, pH9.6,
Na 2cO 31.5g, NaHCO 32.9g, Na 2n 30.2g, adds distilled water and is settled to 1000ml, be adjusted to pH9.45-9.75;
(2) bag is by stabilizing solution: the aqueous solution of 1% casein+5% sucrose,
Sucrose 5g, casein 1g, add distilled water and be settled to 1000ml dissolving, regulate pH value to 7.15-7.25;
(3) confining liquid: 10% calf serum+0.02mol/L PBS (pH7.4)
100ml calf serum joins the 0.02mol/L phosphate buffer prepared and dissolves quantitatively to 1000ml;
(4) sample diluent: 10% bovine serum albumin+0.01mol/L phosphate buffer PBS (pH7.4), 100g calf serum, 8.0gNaCl, 0.2gKH 2pO 4, 2.9gNa 2hPO 412H 2o, 0.2gKCl, 0.1g thimerosal, 1g antiseptic ProClin300, adds distilled water and is settled to 1000ml, be adjusted to pH7.4, to obtain final product;
(5) cleansing solution: 0.01mol/L PBS (pH7.4)+0.05%Tween-20PBST:
NaCl 8.0g, KH 2pO 40.2g, Na 2hPO 412H 2o 2.9g, KCl 0.2g, Tween 20 0.5ml, thimerosal 0.1g, add distilled water and be settled to 1000ml, be adjusted to pH7.4, obtain final product;
(6) ELIAS secondary antibody: the rabbit anti-Hb poly-IgG of (rabbit anti-Hb poly-IgG of HRP mark) horseradish peroxidase-labeled,
Composition: 0.2mL horseradish peroxidase-labeled helicobacter pylori anti-human igg damping fluid, use after adding sample diluent by 1:100, containing 0.02% methyl-isothiazol ketone and 0.02% bromine nitro dioxan and 0.02% other washing isothiazole ketones as antiseptic;
(7) substrate solution: TMB-H 2o 2urea liquid,
Preparation: 1. substrate solution A:3, absolute ethyl alcohol 100ml, added distilled water and was settled to 1000ml for-tetramethyl benzidine, TMB, TMB200mg 3 ', 5,5 ',
2. substrate solution B damping fluid (0.1mol/L citric acid-0.2mol/L sodium hydrogen phosphate damping fluid, pH5.0 ~ 5.4): Na 2hPO 414.60g, citric acid 9.33g, 0.75% hydrogen peroxide urea 6.4ml, adds distilled water and is settled to 1000ml, be adjusted to pH5.0 ~ 5.4;
3. substrate solution A and B is pressed 1:1 mixing, TMB-H 2o 2urea liquid;
(8) stop buffer: (2mol/L H 2sO 4solution): preparation: the 100ml98% concentrated sulphuric acid adds in 600ml distilled water, is settled to 1000ml, room temperature preservation;
(9) titer
Composition: 1.5mL is containing human serum anti-helicobacter pylori IgG titer+0.1% antiseptic ProClin300;
(10) negative controls
Composition: 1.5mL is containing human serum anti-helicobacter pylori IgG negative controls+0.1% antiseptic ProClin300;
(11) positive control solution
Composition: 1.5mL is containing human serum anti-helicobacter pylori IgG positive control solution+0.1% antiseptic ProClin300;
(12) sealing of hole film: hatch for 3 and use plastic seal pore membrane.
2, key instrument
(1) microplate reader: BIO-RAD Model 550
(2) ELISA reaction plate: Corning Incorporated Costar R 96Well EIA/RIA plate
3, method
The selection of the suitableeest titre of 3.1 ELIAS secondary antibody
A) get 96 hole ELISA Plate one piece, use 100ng/ml human IgG, 110 4 DEG C, μ l/ hole bags are spent the night, and cleansing solution washes plate 3 times, 350 μ l/ holes, dry;
B) by how anti-for enzyme mark anti-human igg do a series of dilution with dilution after add respectively and wrapped in the hole of quilt, 100 μ l/ holes, hatch 40min for 37 DEG C, and rear cleansing solution washes plate 3 times, 350 μ l/ holes, dry;
C) add substrate colour developing, every hole adds substrate solution 100 μ l, and 37 DEG C or room temperature lucifuge develop the color 15 minutes; After add stop buffer 50 μ l cessation reaction, microplate reader reads 450nm wavelength place absorbance, i.e. A value, get the enzyme labelled antibody dilutability of A value 1.0 time, the suitableeest titre as ELIAS secondary antibody is 1:1000.
3.2 Checkerboard titration methods select the suitableeest titre of envelope antigen
(1) 96 hole ELISA Plate one piece is got; Get after antigen is done a series of dilution by Heliobacter pylori antigen coating buffer and carry out bag quilt, every hole 110 μ l, 37 DEG C of incubators spend the night oven dry; 10% calf serum 37 DEG C that the antigen coated microplate that getting spends the night dries adds 200 μ l PBS dilutions closes 1.5 hours, obtains the antigen coated enzyme reaction plate of gradient dilution;
(2) strong positive reference serum, weak positive reference serum and negative reference serum sample diluent are doubly diluted by 1:100, application of sample, insulation, washing.
(3) add the enzyme mark anti-human igg of diluting by the suitableeest titre to resist, insulation, washing more.
(4) add substrate colour developing, in microplate reader, read 450nm wavelength place absorbance after acid adding cessation reaction, i.e. A value,
(5) select that the A value of strong positive reference serum is between 1.8 ~ 2.0, the A value of negative reference serum is less than the dilutability of the envelope antigen of 0.2 as the suitableeest titre, the suitableeest bag of this kit is 1:1000 dilution by the dilutability of Heliobacter pylori antigen, 100 μ l/ holes.
The preparation of 3.3 titers
After collecting 100 parts of positive serum mixing, concentrated and purified through Protein A tubing string affinity chromatography, ultimate density is that 2.0mg/ml is decided to be 100EIU unit.
3.4 Heliobacter pylori antigen bags are by the preparation method of reaction plate
Get 96 hole ELISA Plate one piece, Heliobacter pylori antigen coating buffer is diluted in 1:1000 ratio, then wrapper sheet, every hole 110 μ l; 37 DEG C of incubators spend the night oven dry; 10% calf serum 37 DEG C that the antigen coated microplate that getting spends the night dries adds 200 μ l PBS dilutions closes 1.5 hours, obtains antigen coated enzyme reaction plate..
3.5 kit assemblings
Helicobacter pylori IgG Antibodies ELISA half-quantitative detection kit, is made up of by enzyme reaction plate, sample diluent, cleansing solution, ELIAS secondary antibody, substrate solution, stop buffer, positive control solution, negative controls and titer above-mentioned Heliobacter pylori antigen bag.
Specifically be divided into:
(1) sample diluent: containing the phosphate buffer (PBS) of the 0.01M pH7.4 of 10% bovine serum albumin and 0.1%ProClin300;
(2) cleansing solution: the phosphate buffer (PBST) of the 0.01mol/L pH7.4 containing 0.05%Tween 20;
(3) ELIAS secondary antibody: the rabbit anti-Hb poly-IgG of horseradish peroxidase-labeled;
(4) substrate solution: TMB-H 2o 2urea liquid;
(5) stop buffer: 2mol/L H 2sO 4solution;
(6) negative controls: containing human serum base helicobacter pylori IgG negative controls;
(7) positive control solution: containing human serum base helicobacter pylori IgG positive control solution;
(8) titer: containing human serum base helicobacter pylori IgG titer.
3.5 utilize mentioned reagent box to adopt ELISA method to detect Helicobacter pylori IgG Antibodies in serum
3.5.1 prepare before test
All reagent and micro reaction plate are returned to room temperature (20 ~ 25 DEG C).Concentrated cleaning solution (i.e. 100ml cleansing solution+900ml distilled water or deionized water) is diluted with 1:10.Quick-thawing sample in water-bath (room temperature) also mixes.When almost dissolving completely, be placed in trash ice bath.Instructions should be read over before test.All blank solutions, titer, contrast liquid and sample is recommended all to do the test of multiple hole.Each experiment all should carry out the test of blank solution, titer and contrast liquid.
3.5.2 Sample Dilution application of sample
With dilution, blood plasma or serum sample are diluted 200 times (5 μ l sample+995 μ l dilutions), fully mix.
Abundant mixing reagent and the sample diluted, sample (the S1 adding 100 μ l dilutions (blank), titer (standard), negative controls (feminine gender), positive control solution (positive) respectively and dilute in reacting hole, S2, S3 etc.), do multiple hole test (with reference to table 1).After sealing of hole film shrouding, at 37 DEG C, hatch 30 minutes.
Table 1 application of sample example
1 2 3 4 5
A Blank Blank
B Standard Standard
C Negative Negative
D Positive Positive
E S1 S1
F S2 S2
G S3 S4
H Other sample Other sample
3.5.3 wash: after the cleansing solution 350 μ l that every hole is diluted rinses 3 times, be inverted microwell plate knocking several on clean thieving paper.Suggestion second step uses 8 channel pipettor to the 6th step.
3.5.4 ELIAS secondary antibody is added: diluted 100 times (such as: 40 μ l enzyme mark liquid+3960 μ l dilutions) by enzyme mark liquid with dilution, fully mix, each hole adds the enzyme mark liquid that 100 μ l have mixed respectively.After sealing of hole film shrouding, at 37 DEG C, hatch 30 minutes.
3.5.5 wash: with reference to 3.4.2.2.
3.5.6 substrate solution is added: each hole adds the substrate solution that 100 μ l have mixed.After substrate solution adds the first lath, start timing, under room temperature (20 ~ 25 DEG C), hatch 30 minutes, avoid illumination.
3.5.7 stop buffer is added: each hole adds the stop buffer that 100 μ l have mixed.
3.5.8 microplate reader measures: in 30 minutes, at 450nm wavelength place, microplate reader measures absorbance.
3.5.9 result calculates: the mean light absorbency (A) calculating each multiple hole test of blank (dilution), titer, contrast liquid and sample, and the average absorbance value of each test deducts the average absorbance value of blank solution.Enzyme immunizing unit (EIU) is calculated as follows:
Sample=sample; Blank=is blank; Calibrator=titer
[reference value (term of reference)]
Negative < 30EIU
The positive >=30EIU
3.6 specificity experiments
The antigen coated enzyme reaction plate ELISA kit of the full bacterium of helicobacter pylori is adopted to detect with helicobacter pylori standard I gG positive serum, japanese encephalitis virus IgG positive serum, measles virus IgG positive serum, rubella virus IgG positive serum, human cytomegalovirus IgG positive serum and helicobacter pylori standard I gG negative serum, P/N value is respectively 6.23,1.22,1.15,1.27 and 1.06, illustrates that this kit specificity is good.
3.7 clinical samples detect
INOVA Inc Bioisystech Co., Ltd Helicobacter pylori IgG Antibodies ELISA detection kit is adopted to detect 700 routine normal human serums, wherein positive 400 examples of IgG antibody, negative 300 examples, adopt the full bacterium of helicobacter pylori antigen coated enzyme reaction plate method testing result to be 98.5% with INOVA company helicobacter pylori IgG ELISA detection kit phase specific sensitivity, specificity is 98.7%.
Table 1 two kinds of kit IgG testing results compare
Meter sensitivity=98.5%, specificity=98.7%.
3.8 kit assay Performance Evaluations
With reference to the content of national regulations and standard, formulate the quality standard of this product.Based on this standard, we assess the analytical performance of product, and result of study shows that every analytical performance is good, and concrete outcome is as follows:
3.8.1 accuracy: join in normal serum with the Helicobacter pylori IgG Antibodies of concentration known, its recovery should between 90%-110%.
3.8.2 difference between batch; With the sample 10 times that the concentration of the helicobacter pylori IgG detection kit duplicate detection helicobacter pylori IgG of three different lot numbers is 20-30EIU, calculate mean value M and the standard deviation SD of 10 measurement results, coefficient of variation CV is drawn according to formula CV=SD/M × 100%, the difference between batch CV scope of serum sample is 4.2-7.0%, and the difference between batch CV scope of the plasma sample of EDTA anti-freezing is 4.2-8.1%.
3.8.3 criticize interpolation: the sample duplicate detection 10 times by the concentration of helicobacter pylori IgG being 20-30EIU, calculate mean value M and the standard deviation SD of 10 measurement results, draw coefficient of variation CV according to formula CV=SD/M × 100%.Batch interpolation CV scope of serum sample is 3.8-4.6%, and batch interpolation CV scope of the plasma sample of EDTA anti-freezing is 3.5-4.9%.
3.8.4 susceptibility is analyzed: the value being determined minimum quantitative limit by the dilution series (diluting by dilution buffer) of examination criteria liquid (definite concentration is marked on label, is about 100EIU).Dilution series is stoste, 1:2,1:4,1:8,1:16, l:32 and 1:64.The sample (namely each dilutability 10 parts repeats 10 times) of each dilution series is added respectively in the reacting hole of microwell plate.Calculate mean absorbance and each dilution concentration value.
Blank detectability (LoB): 1.1EIU.
Lowest detectable limit (LoD): 1.8EIU.
3.8.5 stability study
The accelerated test behavior pattern of 8 days is studied after placing 14 months to continuous 3 batches of products under 2-8 DEG C of condition and under 37 DEG C of conditions, measures reagent end properties, observes sample with or without mass change.Test result shows, this product is steady quality with this understanding, meets the requirements.

Claims (2)

1. a Helicobacter pylori IgG Antibodies ELISA half-quantitative detection kit, it is characterized in that: be made up of by enzyme reaction plate, sample diluent, cleansing solution, ELIAS secondary antibody, substrate solution, stop buffer, positive control solution, negative controls and titer Heliobacter pylori antigen bag
The antigen coated enzyme reaction plate of described helicobacter pylorus is prepared from through the following steps:
(1) 96 hole ELISA Plate one piece is got;
(2) multiple of Heliobacter pylori antigen coating buffer by 1:1000 is diluted, the antigen liquid diluted is added 110 μ l in each ELISA Plate hole, ELISA Plate is inserted in wet box, spent the night at 2-8 DEG C of bag
(3) clean with cleansing solution: with cleansing solution cleaning bag by the ELISA Plate of spending the night, every hole adds 350ul cleansing solution, cleans 2-4 time;
(4) stabilizing buffer is added: every hole adds 150ul stabilizing buffer, hatches 2-4 hour, then drain under 18-25 DEG C of condition;
(5) get the antigen coated microplate drained and add 10% bovine serum albumin of 200 μ l PBS dilutions at 37 DEG C of closed 1-2 hour, obtain antigen coated enzyme reaction plate;
(6) pack: with packaging of aluminium foil bag, and put into drying agent in bag, be stored in the freezer of 2-8 DEG C after packaging;
Described coating buffer: 0.05mol/L carbonate buffer solution (pH9.6) 0.75g sodium carbonate, 1.46g sodium bicarbonate, adds deionized water and is settled to 500ml;
Described sample diluent: the phosphate buffer (PBS) of 10% bovine serum albumin+0.1%ProClin300+0.01M pH7.4;
Described cleansing solution: the phosphate buffer (PBST) of 0.05%Tween 20+0.01mol/L pH7.4;
Described ELIAS secondary antibody: the rabbit anti-Hb poly-IgG of horseradish peroxidase-labeled;
Described substrate solution: TMB-H 2o 2urea liquid;
Described stop buffer: 2mol/L H 2sO 4solution;
Described negative controls: containing human serum base helicobacter pylori IgG negative controls;
Described positive control solution: containing human serum base helicobacter pylori IgG positive control solution;
Described titer: containing human serum base helicobacter pylori IgG titer.
2. the application of a kind of Helicobacter pylori IgG Antibodies ELISA half-quantitative detection kit according to claim 1 in ELISA method detection serum in Helicobacter pylori IgG Antibodies.
CN201510219965.4A 2015-04-30 2015-04-30 Helicobacter pylori IgG antibody ELISA semi-quantitative detection kit and application thereof Pending CN104833804A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201510219965.4A CN104833804A (en) 2015-04-30 2015-04-30 Helicobacter pylori IgG antibody ELISA semi-quantitative detection kit and application thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201510219965.4A CN104833804A (en) 2015-04-30 2015-04-30 Helicobacter pylori IgG antibody ELISA semi-quantitative detection kit and application thereof

Publications (1)

Publication Number Publication Date
CN104833804A true CN104833804A (en) 2015-08-12

Family

ID=53811816

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201510219965.4A Pending CN104833804A (en) 2015-04-30 2015-04-30 Helicobacter pylori IgG antibody ELISA semi-quantitative detection kit and application thereof

Country Status (1)

Country Link
CN (1) CN104833804A (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106802345A (en) * 2017-01-13 2017-06-06 广州华弘生物科技有限公司 A kind of helicobacter pylori IgG antibody enzyme-linked immunologic diagnosis kit
WO2019011125A1 (en) * 2017-07-11 2019-01-17 深圳市伯劳特生物制品有限公司 Composition for elisa kit and kit for detecting spectrum of helicobacter pylori antibody and preparation method thereof
CN110470845A (en) * 2019-07-18 2019-11-19 镇江德威乐普能源环保科技有限公司 Helicobacter pylori CagL protein detection kit and its detection method
CN111190017A (en) * 2019-12-11 2020-05-22 深圳爱信生物技术有限公司 Sensitization blocking buffer solution and application thereof

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1140257A (en) * 1995-07-06 1997-01-15 中国预防医学科学院流行病学微生物学研究所 External human serum anti-helicobacterium pylori urease antibody testing reagent box
CN2482085Y (en) * 2001-04-29 2002-03-13 苏荣仁 Quick helicobacter pylori antigen testing kit
WO2008126111A1 (en) * 2007-04-12 2008-10-23 Alma Mater Studiorum-Università Di Bologna A chemosusceptibility rapid test for helicobacter pylori
CN101435821A (en) * 2008-12-19 2009-05-20 周炬华 Immune detection kit of pylori spiral bacilli antibody and detection method thereof
CN102305857A (en) * 2011-08-02 2012-01-04 深圳市亚辉龙生物科技有限公司 Latex immunoreagent for determining helicobacter pylori antibody and detection method thereof
CN102721815A (en) * 2012-04-18 2012-10-10 天津天佛罗生物技术有限公司 Detection kit for helicobacter pylori virulence protein antibody and detection method by using the same
CN103185793A (en) * 2011-12-30 2013-07-03 深圳市亚辉龙生物科技有限公司 Reagent device for detecting helicobacter pylori antibody and method thereof

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1140257A (en) * 1995-07-06 1997-01-15 中国预防医学科学院流行病学微生物学研究所 External human serum anti-helicobacterium pylori urease antibody testing reagent box
CN2482085Y (en) * 2001-04-29 2002-03-13 苏荣仁 Quick helicobacter pylori antigen testing kit
WO2008126111A1 (en) * 2007-04-12 2008-10-23 Alma Mater Studiorum-Università Di Bologna A chemosusceptibility rapid test for helicobacter pylori
CN101435821A (en) * 2008-12-19 2009-05-20 周炬华 Immune detection kit of pylori spiral bacilli antibody and detection method thereof
CN102305857A (en) * 2011-08-02 2012-01-04 深圳市亚辉龙生物科技有限公司 Latex immunoreagent for determining helicobacter pylori antibody and detection method thereof
CN103185793A (en) * 2011-12-30 2013-07-03 深圳市亚辉龙生物科技有限公司 Reagent device for detecting helicobacter pylori antibody and method thereof
CN102721815A (en) * 2012-04-18 2012-10-10 天津天佛罗生物技术有限公司 Detection kit for helicobacter pylori virulence protein antibody and detection method by using the same

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
李子俊等: "酶联免疫吸附法检测唾液中幽门螺杆菌抗体的价值", 《世界华人消化杂志》 *

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106802345A (en) * 2017-01-13 2017-06-06 广州华弘生物科技有限公司 A kind of helicobacter pylori IgG antibody enzyme-linked immunologic diagnosis kit
CN106802345B (en) * 2017-01-13 2018-03-27 广州华弘生物科技有限公司 A kind of helicobacter pylori IgG antibody enzyme-linked immunologic diagnosis kit
WO2019011125A1 (en) * 2017-07-11 2019-01-17 深圳市伯劳特生物制品有限公司 Composition for elisa kit and kit for detecting spectrum of helicobacter pylori antibody and preparation method thereof
CN110470845A (en) * 2019-07-18 2019-11-19 镇江德威乐普能源环保科技有限公司 Helicobacter pylori CagL protein detection kit and its detection method
CN111190017A (en) * 2019-12-11 2020-05-22 深圳爱信生物技术有限公司 Sensitization blocking buffer solution and application thereof

Similar Documents

Publication Publication Date Title
CN112098644B (en) Kit for detecting novel coronavirus neutralizing antibody by enzyme-linked immunosorbent assay and detection method thereof
Peng et al. Comparison of a new gold-immunochromatographic assay for the detection of antibodies against avian influenza virus with hemagglutination inhibition and agar gel immunodiffusion assays
CN102854314B (en) Kit for detecting helicobacter pylori antibody by using latex immunoturbidimetry assay
CN103901215B (en) Chemical luminescent analysis reagent kid of a kind of food allergen and preparation method thereof and detection method
CN101196518A (en) Hepatitis virus type C immune body chemiluminescence method diagnostic reagent kit and its producing method
CN111273017B (en) Fluorescent immunochromatography kit for rapidly detecting novel coronaviruses
CN104833804A (en) Helicobacter pylori IgG antibody ELISA semi-quantitative detection kit and application thereof
CN102353777A (en) Kit and method for testing human cytomegalovirus IgG antibody
CN102368071B (en) Chemiluminescent immunoassay kit for detecting mycoplasma pneumoniae IgM antibody
CN108152511A (en) Coxsack A16 virus antigen polypeptides and its IgM antibody detection kit
CN101592660B (en) Brucellosis indirect enzyme-linked immunosorbent assay milk liquid antibody reagent kit
CN106093383A (en) Porcine reproductive and respiratory syndrome virus antibody ELISA diagnosis reagent kit and preparation method thereof
CN101936997B (en) Human anti-rabies virus IgG antibody ELISA test kit
CN101825635B (en) Reagent strip for joint detection of syphilis specific IgG antibody and specific total antibody and preparation method thereof
CN102368068B (en) Kit for detecting chlamydia pneumoniae IgM antibody
CN105606803B (en) The latex enhancing immune turbidimetry kit of helicobacter pylori antibody content
CN102798718A (en) Previous S1 antigen detection kit for hepatitis B virus and preparation method of previous S1 antigen detection kit
CN108169484A (en) EV71 virus antigen polypeptides and its IgM antibody detection kit
CN107656057A (en) A kind of ELISA kit and its application for being used to detect brucellosis IgM antibody
CN106896224A (en) A kind of swine fever novel antibodies ELISA detection kit
CN102809653A (en) Preparation and application of ELISA (Enzyme-Linked Immunosorbent Assay) kit for detecting novel bunyavirus antigen
Kahane et al. Detection of IgG antibodies specific for measles virus by enzyme-linked immunosorbent assay (ELISA)
CN103217524B (en) Cystic echinococcosis cyst fluid degreasing antigen for detecting alveolar echinococcosis antibody, and preparation method thereof
CN201926664U (en) Kit for immunoblot assay of specific IgG antibody against Treponema pallidum
CN111458498A (en) Hand-foot-mouth EV71 antigen detection kit

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
EXSB Decision made by sipo to initiate substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20150812